SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. Marret, A. Fauconnier, G. Dubernard, H. Misme, L. Lagarce, M. Lesavre, H. Fernandez, C. Mimoun, C. Tourette, S. Curinier, B. Rabishong, A. Agostini, États des lieux et expertise de l’usage hors AMM du méthotrexate en gynécologie–obstétrique : travail du CNGOF, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2015, 44, 3, 230

    CrossRef

  2. 2
    H. Marret, A. Fauconnier, G. Dubernard, H. Misme, L. Lagarce, M. Lesavre, H. Fernandez, C. Mimoun, C. Tourette, S. Curinier, B. Rabishong, A. Agostini, États des lieux et expertise de l’usage hors AMM du méthotrexate en gynécologie–obstétrique : travail du CNGOF, La Revue Sage-Femme, 2015, 14, 3, 114

    CrossRef

  3. 3
    Matteo Lambertini, Nermine S Kamal, Fedro A Peccatori, Lucia Del Mastro, Hatem A Azim, Exploring the safety of chemotherapy for treating breast cancer during pregnancy, Expert Opinion on Drug Safety, 2015, 1

    CrossRef

  4. 4
    L. Lagarce, M. Zenut, P. Lainé-Cessac, Pharmacologie du méthotrexate, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2015, 44, 3, 203

    CrossRef

  5. 5
    Sohye Kang, Pavel V Bondarenko, Rohini Deshpande, Productivity: a minor consideration when looking at mammalian cell culture performance from the systems perspective, Pharmaceutical Bioprocessing, 2015, 3, 1, 5

    CrossRef

  6. 6
    Melissa B Hoffman, Michael Farhangian, Steven R Feldman, Psoriasis during pregnancy: characteristics and important management recommendations, Expert Review of Clinical Immunology, 2015, 11, 6, 709

    CrossRef

  7. 7
    Zenas Z. N. Yiu, Richard B. Warren, Ulrich Mrowietz, Christopher E. M. Griffiths, Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes, Journal of Dermatological Treatment, 2015, 26, 4, 329

    CrossRef

  8. 8
    Khadija H. Chaudrey, Sunanda V. Kane, Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy, Current Treatment Options in Gastroenterology, 2015, 13, 1, 77

    CrossRef

  9. 9
    Jan M. Friedman, Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  10. 10
    Leon P McLean, Raymond K Cross, Adverse events in IBD: to stop or continue immune suppressant and biologic treatment, Expert Review of Gastroenterology & Hepatology, 2014, 8, 3, 223

    CrossRef

  11. 11
    S. A. Rasmussen, S. Hernandez-Diaz, O. A. Abdul-Rahman, L. Sahin, C. R. Petrie, K. M. Keppler-Noreuil, S. E. Frey, R. M. Mason, M. Nesin, J. C. Carey, Assessment of Congenital Anomalies in Infants Born to Pregnant Women Enrolled in Clinical Trials, Clinical Infectious Diseases, 2014, 59, suppl 7, S428

    CrossRef

  12. 12
    D. Milojkovic, J. F. Apperley, How I treat leukemia during pregnancy, Blood, 2014, 123, 7, 974

    CrossRef

  13. 13
    April L. Dawson, Tiffany Riehle-Colarusso, Jennita Reefhuis, J. Fernando Arena, Maternal exposure to methotrexate and birth defects: A population-based study, American Journal of Medical Genetics Part A, 2014, 164, 9
  14. 14
    E. Elefant, Médicaments et grossesse : aide pour l’échographiste, Revue de médecine périnatale, 2014, 6, 1, 39

    CrossRef

  15. 15
    María Cecilia Martín, Pablo Barbero, Boris Groisman, Miguel Ángel Aguirre, Gideon Koren, Methotrexate embryopathy after exposure to low weekly doses in early pregnancy, Reproductive Toxicology, 2014, 43, 26

    CrossRef

  16. 16
    Corinna Weber-Schoendorfer, Christina Chambers, Evelin Wacker, Delphine Beghin, Nathalie Bernard, Svetlana Shechtman, Diana Johnson, Benedikte Cuppers-Maarschalkerweerd, Alessandra Pistelli, Maurizio Clementi, Ursula Winterfeld, Georgios Eleftheriou, Anna Pupco, Kelly Kao, Heli Malm, Elisabeth Elefant, Gideon Koren, Thierry Vial, Asher Ornoy, Reinhard Meister, Christof Schaefer, Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study, Arthritis & Rheumatology, 2014, 66, 5
  17. 17
    Maria Gerosa, Pier Luigi Meroni, Rolando Cimaz, Safety considerations when prescribing immunosuppression medication to pregnant women, Expert Opinion on Drug Safety, 2014, 13, 12, 1591

    CrossRef

  18. 18
    Monika Østensen, Frauke Förger, How safe are anti-rheumatic drugs during pregnancy?, Current Opinion in Pharmacology, 2013, 13, 3, 470

    CrossRef

  19. 19
    Olubukola Babalola, Bruce E. Strober, Management of psoriasis in pregnancy, Dermatologic Therapy, 2013, 26, 4
  20. 20
    Tseng-Ting Kao, Gang-Hui Lee, Chi-Chang Fu, Bing-Hung Chen, Li-Ting Chen, Tzu-Fun Fu, Methotrexate-Induced Decrease in Embryonic 5-Methyl-Tetrahydrofolate Is Irreversible with Leucovorin Supplementation, Zebrafish, 2013, 10, 3, 326

    CrossRef

  21. 21
    Kate MacDonald, Wendy V. Norman, Oana Popescu, New anomalies due to methotrexate and misoprostol exposure in early pregnancy, International Journal of Gynecology & Obstetrics, 2013, 122, 3, 267

    CrossRef

  22. 22
    Gert Van Assche, C. Janneke van der Woude, Axel Dignass, Reply to Drs. Silva and Santana's letter, Journal of Crohn's and Colitis, 2013, 7, 4, e152

    CrossRef

  23. 23
    Olubukola Babalola, Bruce E. Strober, Treatment of atopic dermatitis in pregnancy, Dermatologic Therapy, 2013, 26, 4
  24. 24
    Kurt T. Barnhart, Early pregnancy failure: beware of the pitfalls of modern management, Fertility and Sterility, 2012, 98, 5, 1061

    CrossRef

  25. 25
    Michael Levine, Ayrn D. O'Connor, Obstetric Toxicology, Emergency Medicine Clinics of North America, 2012, 30, 4, 977

    CrossRef